J 2156
Modify Date: 2024-01-22 13:01:04
J 2156 structure
|
Common Name | J 2156 | ||
|---|---|---|---|---|
| CAS Number | 2387505-73-7 | Molecular Weight | 582.59 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H29F3N4O6S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of J 2156J-2156 TFA is a high potent, selective somatostatin receptor type 4 (SST4 receptor) agonist with IC50s of 0.05 nM and 0.07 nM for human and rat SST4 receptors, respectively. J-2156 TFA is used for the relief of mechanical allodynia and mechanical hyperalgesia in the ipsilateral hindpaws in rats[1][2]. |
| Name | J-2156 TFA |
|---|
| Description | J-2156 TFA is a high potent, selective somatostatin receptor type 4 (SST4 receptor) agonist with IC50s of 0.05 nM and 0.07 nM for human and rat SST4 receptors, respectively. J-2156 TFA is used for the relief of mechanical allodynia and mechanical hyperalgesia in the ipsilateral hindpaws in rats[1][2]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.05 nM (human SST4) and 0.07 nM (rat SST4)[1] |
| In Vitro | J-2156 TFA binds with nanomolar affinity to the human somatostatin receptor subtype 4 (h sst4: Ki=1.2 nM) and is over 400-fold subtype-selective against the other somatostatin receptors (h sst1: Ki=1.2 nM; h sst2: Ki>5000 nM; h sst3: Ki=1400 nM; h sst5: Ki=540 nM) in Chinese hamster ovary (CHO) cells[2]. |
| In Vivo | J-2156 TFA (1-10 mg/kg; i.p.; for 3 hours) of single bolus doses has anti-allodynic effect on ipsilateral and contralateral in BCIBP-rats[1]. Animal Model: Breast cancer-induced bone pain (BCIBP)-rats[1] Dosage: 1, 3, 10 mg/kg Administration: IP; for 3 hours Result: Had anti-allodynic effect on ipsilateral and contralateral in BCIBP-rats. |
| References |
| Molecular Formula | C26H29F3N4O6S |
|---|---|
| Molecular Weight | 582.59 |